We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

See more

16 May 2007 By Robert Cyran

The US contact lens group has certainly been a dog. Its fleas include improper accounting, product recalls and liability lawsuits. But Bausch & Lomb is rapidly sorting out these problems. Shareholders should demand more than Warburg Pincus is offering.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)